Association between the NAT1 1095C > A polymorphism and homocysteine concentration [3]

American Journal of Medical Genetics, Part A

Volumn 140, Issue 21, 2006, Pages 2374-2377

  Stanisławska Sachadyn, Anna ^a   Jensen, Liselotte E ^a   Kealey, Carmel ^a   Woodside, Jayne V ^b   Young, Ian S ^b   Scott, John M ^d   Murray, Liam ^b   Boreham, Colin A ^c   McNulty, Helene ^c   Strain, J J ^c   Whitehead, Alexander S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF ULSTER   (United Kingdom)

^d TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ACYLTRANSFERASE 1; BIOCHEMICAL MARKER; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALLELE; BIRTH DEFECT; CLEFT FACE; FEMALE; FOLATE METABOLISM; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HOMOZYGOTE; HUMAN; LETTER; MALE; NAT1 GENE; PHENOTYPE; PRIORITY JOURNAL; SMOKING; WILD TYPE;

ADULT; ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; BASE SEQUENCE; DNA PRIMERS; FEMALE; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; ISOENZYMES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; VITAMIN B 12;

EID: 33750597595     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31475     Document Type: Letter

References (23)

1. Badawi AF, Hirvonen A, Bell DA, Lang NP, Kadlubar FF. 1995. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res 55:5230-5237.
2. Bell DA, Badawi AF, Lang NP, Ilett KF, Kadlubar FF, Hirvonen A. 1995. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: Association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 55:5226-5229.
3. Boreham CA, Twisk J, Savage MJ, Cran GW, Strain JJ. 1997. Physical activity, sports participation, and risk factors in adolescents. Med Sci Sports Exercise 29:788-793.
4. Boreham C, Twisk J, van Mechelen W, Savage M, Strain J, Cran G. 1999. Relationships between the development of biological risk factors for coronary heart disease and lifestyle parameters during adolescence: The Northern Ireland Young Hearts Project. Public Health 113:7-12.
5. Brockton N, Little J, Sharp L, Cotton SC. 2000. N-acetyltransferase polymorphisms and colorectal cancer: A HuGE review. Am J Epidemiol 151:846-861.
6. Brown KS, Kluijtmans LA, Young IS, Murray L, McMaster D, Woodside JV, Yarnell JW, Boreham CA, McNulty H, Strain JJ, McPartlin J, Scott JM, Mitchell LE, Whitehead AS. 2004. The 5,10-methylenetetrahydrofolate reductase C677T polymorphism interacts with smoking to increase homocysteine. Atherosclerosis 174:315-322.
7. Grant DM, Hughes NC, Janezic SA, Goodfellow GH, Chen HJ, Gaedigk A, Yu VL, Grewal R. 1997. Human acetyltransferase polymorphisms. Mutat Res 376:61-70.
8. Hein DW. 2002. Molecular genetics and function of NAT1 and NAT2: Role in aromatic amine metabolism and carcinogenesis. Mutat Res 506-507:65-77.
9. Hein DW, McQueen CA, Grant DM, Goodfellow GH, Kadlubar FF, Weber WW. 2000. Pharmacogenetics of the arylamine N-acetyltransferases: A symposium in honor of Wendell W. Weber. Drug Metab Dispos 28:1425-1432.
10. Jensen LE, Hoess K, Whitehead AS, Mitchell LE. 2005. The NAT1 C1095A polymorphism, maternal multivitamin use and smoking, and the risk of spina bifida. Birth Defects Res A Clin Mol Teratol 73:512-516.
11. Kluijtmans LA, Young IS, Boreham CA, Murray L, McMaster D, McNulty H, Strain JJ, McPartlin J, Scott JM, Whitehead AS. 2003. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood 101:2483-2488.
12. Lammer EJ, Shaw GM, Iovannisci DM, Finnell RH. 2004a. Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 (NAT1), and risk for orofacial clefts. Birth Defects Res 70:846-852.
13. Lammer EJ, Shaw GM, Iovannisci DM, Van Waes J, Finnell RH. 2004b. Maternal smoking and the risk of orofacial clefts: Susceptibility with NAT1 and NAT2 polymorphisms. Epidemiology 15:150-156.
14. McDonald SD, Walker MC. 2001. Homocysteine levels in pregnant women who smoke cigarettes. Med Hypotheses 57:792-796.
15. Medina M, Urdiales JL, Amores-Sanchez MI. 2001. Roles of homocysteine in cell metabolism: Old and new functions. Eur J Biochem 268:3871-3882.
16. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM. 1995. Homocysteine metabolism in pregnancies complicated by neural tube defects. Lancet 345:149-151.
17. Minchin RF. 1995. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. Biochem J 307:1-3.
18. Molloy AM, Scott JM. 1997. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol 281:43-53.
19. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland M, Kvale G. 1995. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274:1526-1533.
20. Prescott NJ, Winter RM, Malcolm S. 2002. Maternal MTHFR genotype contributes to the risk of non-syndromic cleft lip and palate. J Med Genet 39:368-369.
21. Ubbink JB, Hayward Vermaak WJ, Bissbort S. 1991. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565:441-446.
22. Ward A, Summers MJ, Sim E. 1995. Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterization of its potential role in folate metabolism. Biochem Pharmacol 49:1759-1767.
23. Yang M, Katoh T, Delongchamp R, Ozawa S, Kohshi K, Kawamoto T. 2000. Relationship between NAT1 genotype and phenotype in a Japanese population. Pharmacogenetics 10:225-232.